Science

May 8, 2025, 14:27

Myeloma Paper of the Day, May 8th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Dysregulated immune proteins in plasma (SLAMF7, TNFRSF17 (BCMA), QPCT, SLAMF1, CNTN5, BAFF (TNFSF13B)) in the UK Biobank may predict myeloma up to 12 years before clinical diagnosis.”

Title: Dysregulated immune proteins in plasma in the UK Biobank predict Multiple Myeloma 12 years before clinical diagnosis

Authors: Joshua Fieggen, Anshul Thakur, Christopher C Butler, Karthik Ramasamy, Anjan Thakurta, David A Clifton, Lei Clifton.

Read the Full Article in Blood Advances.

More posts featuring Robert Orlowski.

Anjan Thakurta Anshul Thakur blood advances cancer Christopher C Butler David A Clifton Joshua Fieggen Karthik Ramasamy Lei Clifton multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski

Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking

Joe Biden Diagnosed with Aggressive Metastatic Prostate Cancer at Age 82

DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer

FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial

New World Cancer Declaration 2025–2035 by UICC